BANK OF AMERICA CORP /DE/ - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 11 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$327,000
-43.8%
1,422,496
-12.7%
0.00%
Q4 2021$582,000
+719.7%
1,629,198
+1292.5%
0.00%
Q3 2021$71,000
-58.5%
116,995
-24.3%
0.00%
Q2 2021$171,000154,611
+2576750.0%
0.00%
Q1 2021$060.0%0.00%
Q4 2020$06
+500.0%
0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.00%
Other shareholders

There were no reported owners of TONIX PHARMACEUTICALS HLDG C in Q4 2019.

NameSharesValueWeighting ↓
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders